You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 17, Issue 8

April-2 2025 - 129 articles

Cover Story: ESR1 resistance mutations are common in patients with breast cancer previously treated with anti-hormonal therapy. Elacestrant, an FDA- and EMA-approved oral drug, targets ESR1-positive tumors. Therefore, it is necessary to develop and validate sensitive assays to detect ESR1 mutations that allow clinicians to determine eligibility for treatment with Elacestrant. We use real-world patient data from two pathology laboratories in Germany to highlight the rarity of ESR1 mutations in hormonal therapy-naïve patients (n = 5106), compare molecular detection approaches, and demonstrate the general distribution and pattern of occurrence of these mutations in patients with breast cancer as detected by a novel NGS panel (n = 354). Our results are intended to inform future practices and approaches to molecular diagnostics used in making therapeutic decisions. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (129)

  • Systematic Review
  • Open Access
1 Citations
1,321 Views
15 Pages

Rectovaginal Extra-Gastrointestinal Stromal Tumors (EGISTs): A Systematic Review of the Literature and a Pooled Survival Analysis

  • Eleni Papamattheou,
  • Ioannis Katsaros,
  • Stavros P. Papadakos,
  • Evangelos Lianos and
  • Elissaios Kontis

21 April 2025

Background/Objectives: Extra-gastrointestinal stromal tumors (EGISTs) are rare mesenchymal tumors arising outside the gastrointestinal tract, making up <5% of all GISTs. Rectovaginal EGISTs are particularly uncommon, with limited available data. T...

  • Review
  • Open Access
1,810 Views
24 Pages

21 April 2025

Cancer is biologically diverse, highly heterogeneous, and associated with molecular alterations, significantly contributing to mortality worldwide. Currently, cancer patients are subjected to single or combination treatments comprising chemotherapy,...

  • Article
  • Open Access
3 Citations
1,450 Views
27 Pages

21 April 2025

Background/Objectives: Immune cells determine the role of the tumor microenvironment during tumor progression, either suppressing tumor formation or promoting tumorigenesis. This study aimed to fully characterize immune cell responses during skin tum...

  • Article
  • Open Access
2,411 Views
12 Pages

21 April 2025

Family caregivers (FCs) play a vital role in supporting terminally ill patients with cancer by providing emotional, physical, and practical care throughout the illness trajectory [...]

  • Review
  • Open Access
1 Citations
1,844 Views
29 Pages

Interplay Between the Cytoskeleton and DNA Damage Response in Cancer Progression

  • Clarissa Esmeralda Halim,
  • Shuo Deng,
  • Karen Carmelina Crasta and
  • Celestial T. Yap

21 April 2025

DNA damage has emerged as a critical factor in fuelling the development and progression of cancer. DNA damage response (DDR) pathways lie at the crux of cell fate decisions following DNA damage induction, which can either trigger the repair of detrim...

  • Review
  • Open Access
1,317 Views
17 Pages

The Role of Visfatin in Gastric and Esophageal Cancer: From Biomarker to Therapeutic Target

  • Adam Mylonakis,
  • Alexandros Kozadinos,
  • Maximos Frountzas,
  • Emmanouil I. Kapetanakis,
  • Irene Lidoriki,
  • Markos Despotidis,
  • Eva Karanikki,
  • Tania Triantafyllou,
  • Dimitrios Theodorou and
  • Konstantinos G. Toutouzas
  • + 1 author

21 April 2025

Background: Gastric and esophageal cancers are among the most lethal malignancies worldwide, necessitating improved biomarkers and therapeutic targets to improve patient outcomes. Visfatin, also known as nicotinamide phosphoribosyltransferase (NAMPT)...

  • Article
  • Open Access
1 Citations
845 Views
21 Pages

High-Speed Videoendoscopy and Stiffness Mapping for AI-Assisted Glottic Lesion Differentiation

  • Magdalena M. Pietrzak,
  • Justyna Kałuża-Olszewska,
  • Ewa Niebudek-Bogusz,
  • Artur Klepaczko and
  • Wioletta Pietruszewska

21 April 2025

Objectives: This study evaluates the potential of high-speed videoendoscopy (HSV) in differentiating between benign and malignant glottic lesions, offering a non-invasive diagnostic tool for clinicians. Moreover, a new parameter derived from high-spe...

  • Review
  • Open Access
1 Citations
1,848 Views
31 Pages

21 April 2025

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths. The 5-year survival rate has been estimated to be less than 20% while its incidence rates have more than tripled since the 1980s. Astrocyte elevated gene-1/Metadher...

  • Article
  • Open Access
1 Citations
1,433 Views
19 Pages

Histology-Specific Treatment Strategies and Survival Prediction in Lung Cancer Patients with Spinal Metastases: A Nationwide Analysis

  • Abdul Karim Ghaith,
  • Xinlan Yang,
  • Taha Khalilullah,
  • Xihang Wang,
  • Melanie Alfonzo Horowitz,
  • Jawad Khalifeh,
  • A. Karim Ahmed,
  • Tej Azad,
  • Joshua Weinberg and
  • Abdel-Hameed Al-Mistarehi
  • + 6 authors

21 April 2025

Background/Objectives: Spinal metastases are a common and severe complication of lung cancer, particularly in small cell lung cancer (SCLC), and are associated with poor survival. Despite advancements in treatment, optimal management strategies remai...

  • Article
  • Open Access
2 Citations
1,245 Views
10 Pages

Prognostic Value of Systemic Inflammatory Markers in Malignant Tumors of Minor Salivary Glands: A Retrospective Analysis of a Single Center

  • Maria Giulia Cristofaro,
  • Francesco Ferragina,
  • Samuel Staglianò,
  • Antonella Arrotta,
  • Marianna D’Amico and
  • Ida Barca

21 April 2025

Background: Malignant tumors of minor salivary glands (MGSTs) are rare and exhibit significant heterogeneity in terms of etiology, histology and prognosis. Methods: This retrospective analysis of 48 resected MGSTs employed Receiver Operating Characte...

of 13

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694